Navigation Links
U.S. Vaccine Market is Expected to Reach USD 17.4 Billion by 2018: Transparency Market Research
Date:9/13/2012

ALBANY, New York, September 13, 2012 /PRNewswire/ --

According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "U.S. Vaccine Market - U.S. Industry Analysis, Size, Share, Growth, And Forecast, 2012 - 2018", the U.S. vaccine market is estimated to be worth USD 12.8 billion in 2012 and is further expected to reach USD 17.4 billion by 2018, growing at a CAGR of 5.3% from 2012 to 2018. Human vaccine segment occupies about 80% of the U.S. vaccine market.

Browse the database at http://www.transparencymarketresearch.com/us-vaccine-market.html 

U.S. will continue to lead the global vaccine market due to rising prevalence of infectious diseases in humans and animals, and advancement in biotechnology in the region. Short functional shelf life of certain vaccines will have negative impact on the market growth, but huge product pipeline of the multinational firms will overcome this concern and will drive the future growth of the market.

Pediatric vaccine segment in the U.S. human vaccine market enjoys high share as well as high growth rate due to government compulsion for child immunization. Adult & adolescent vaccine market is expected to grow moderately over the next six years due to rising awareness and increasing vaccination for human papillomavirus (HPV) and such other viral diseases.

Related & Recently Published Reports by Transparency Market Research

Minimally Invasive Surgery Market


SOURCE Transparency Market Research
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Frost & Sullivan Predicts Growth for the European Vaccines Market
2. Sinovac Receives Beijing CDC Tender Award to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
3. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
4. ImmusanT Initiates Clinical Trials of Nexvax2 Therapeutic Vaccine for Celiac Disease
5. Human Vaccines & Immunotherapeutics Special Focus Highlights a Paradigm Shift in Cancer Vaccine Development
6. As Tuberculosis Grows More Difficult to Control, Vaccine Candidate to Prevent Disease Enters Clinical Testing
7. Major Breakthrough in Hepatitis C Vaccine Development
8. Back to School Ideas: Vaccines for Kids Could Hurt Rather Than Help Fight Disease
9. Vaccines are dangerous, according to Saynotovaccines.org - Get all the facts!
10. Sanofi Pasteur to add 2D barcode to six more vaccines
11. Whats New with Flu this Season: Industry Recommendations, New Vaccines and 100% Paperless Flu Program Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... November 18, 2014 Investor-Edge has initiated ... EXEL ), Geron Corporation (NASDAQ: GERN ), Tekmira ... (NASDAQ: GALE ), and XOMA Corporation (NASDAQ: ... be accessed at: http://investor-edge.com/register . The US ... note as the Dow Jones Industrial Average finished at 17,647.75, ...
(Date:11/18/2014)... , Nov. 18, 2014 Pressure BioSciences, ... announced the installation of its first two Barozyme ... subsequent potential sale. One system was placed in ... of Georgetown University while the other was placed ... In both settings, the Company believes the new ...
(Date:11/18/2014)... MUMBAI , November 18, 2014 ... thorough knowledge of the overall new requirements of application ... China but also provides the guidance ... approval for your products entry into the Chinese medical ... Chinese medical device market is one of segment market ...
Breaking Medicine Technology:Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 2Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 3Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 4Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 5Pressure BioSciences Ships First Two Barozyme HT48 Systems 2Pressure BioSciences Ships First Two Barozyme HT48 Systems 3Pressure BioSciences Ships First Two Barozyme HT48 Systems 4Pressure BioSciences Ships First Two Barozyme HT48 Systems 5Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 2Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 3Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 4Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 5Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 6Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 7Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 8
... Inc. , a company that manufactures and sells a ... in specific markets outside the United States through a ... new BIOSAFE-treated Ultra Sensitive facemasks begin to reduce microorganisms ... and have further proven to be effective against Influenza ...
... , NEW YORK, Oct. 13 Reportlinker.com ... is available in its catalogue. , ... Outlook to 2010: Marketing and Sales Strategies ... , http://www.reportlinker.com/p0154807/Reportlinker-Adds-Global-Drug-Manufacturing-Industry-Outlook-to-2010-Marketing-and-Sales-Strategies-and-the-Impact-of-Recession-and-Recovery.html ...
Cached Medicine Technology:BIOSAFE Launching In a New Specially-Treated Facemask Effective Against H1N1 Influenza 2BIOSAFE Launching In a New Specially-Treated Facemask Effective Against H1N1 Influenza 3BIOSAFE Launching In a New Specially-Treated Facemask Effective Against H1N1 Influenza 4Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 2Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 3Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 4Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 5Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 6Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 7Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 8Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 9Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 10Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 11Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 12Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 13Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 14Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 15Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 16Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 17Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 18Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 19Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 20
(Date:11/18/2014)... Haelle HealthDay Reporter MONDAY, ... experience a severe abusive head trauma before the age of ... new study. In addition, among those who survive ... the study found. Abusive head trauma includes shaken baby ... suffers head injuries, according to background information in the study. ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter ... Daily low-dose aspirin therapy may not have significant heart-health ... The study, which involved more than 14,000 Japanese people ... heart-related deaths or non-fatal heart attacks and strokes between ... "It indicates that primary prevention with daily low-dose ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter , ... stroke patients can safely take aspirin combined with a blood-thinning ... increase a patient,s risk of early death, according to a ... American Heart Association in Chicago. The report was also published ... of data from more than a dozen clinical trials revealed ...
(Date:11/18/2014)... MONDAY, Nov. 17, 2014 (HealthDay News) -- Until recently, insect-transmitted ... America, but it has made its way to the United ... fatal illness is typically transmitted via the bite of the ... night. And now a new study suggests that common bedbugs ... bedbug can acquire and transmit the parasite. Our next step ...
(Date:11/17/2014)... CA (PRWEB) November 17, 2014 A ... thousands of patients throughout the country are turning back ... than ever before. This is because the company has ... to their already impressive collection of prescription and non-prescription ... who have incorporated Diet Doc’s best anti-aging ...
Breaking Medicine News(10 mins):Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 2Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 3Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 4Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 2Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 3Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 2Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 3Health News:Bedbugs Could Be Potential New Source of Tropical Disease in U.S. 2Health News:Bedbugs Could Be Potential New Source of Tropical Disease in U.S. 3Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 2Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 3
... ... commitment to consumer privacy protection , ... Westlake Village, CA and San Francisco, CA (PRWEB) September 1, 2009 ... has been certified to display the TRUSTe Privacy Seal, which demonstrates its commitment to ...
... EDINBURGH, Scotland, September 1 Aircraft Medical,(Aircraft), the UK ... to its R&D, business development and sales teams since January ... staff is in line with the Company,s commitment to,expanding the ... business development and R&D activities. , ...
... The American Academy of Otolaryngology Head and ... only--national clinical practice guideline to help healthcare practitioners ... as dysphonia. The guideline emphasizes evidence-based management of ... prevalence of this common vocal health issue. ...
... , , DENVER, Aug. 31 ... of kidney care services for those diagnosed with chronic kidney disease ... leading health care industry publications, named Kent Thiry, Chairman and CEO ... Healthcare in 2009. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO ) ...
... NASHVILLE, Tenn., Aug. 31 Cumberland Pharmaceuticals Inc. (Nasdaq: ... on hospital acute care and gastroenterology markets, today announced that ... Global Life Sciences Conference in New York at 11:00 a.m. ... provide an update on the Company and its Caldolor product, ...
... Pa., Aug. 31 Endo Pharmaceuticals (Nasdaq: ENDP ) announced today ... Thursday, Sept. 10, 2009, at 2:40 p.m. EDT. Alan Levin, Chief Financial ... , The presentation will be webcast live and can be accessed ... , , About Endo , ...
Cached Medicine News:Health News:The People's Medicine Community Certified to Display TRUSTe Privacy Seal of Approval 2Health News:The People's Medicine Community Certified to Display TRUSTe Privacy Seal of Approval 3Health News:Aircraft Reports Material Expansion and Staff Increase 2Health News:National guideline released for the treatment of hoarseness 2Health News:National guideline released for the treatment of hoarseness 3Health News:DaVita CEO Kent Thiry Honored as One of Modern Healthcare's 100 Most Powerful People in Healthcare 2Health News:Cumberland Pharmaceuticals to Present at UBS Global Life Sciences Conference in New York on September 21, 2009 2Health News:Endo Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 2009 2
... end transcription services. Zodiac offers two ... either submitted over the phone via ... 24 hours a day, 7 days ... recorded on a digital handheld recorder ...
... Achieve high-speed productivity in the lab ... system, dedicated for pre- and post-analytical sorting ... HSS selectively decaps and then sorts primary ... to save time, labor, and eliminate ...
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
Similar to Model 530, but just 37 inches long and with only one drape....
Medicine Products: